company background image
AFX

Carl Zeiss MeditecXTRA:AFX Stock Report

Last Price

€142.05

Market Cap

€12.7b

7D

-3.6%

1Y

8.4%

Updated

21 Jan, 2022

Data

Company Financials +
AFX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends4/6

AFX Stock Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally.

Rewards

Earnings are forecast to grow 9.49% per year

Earnings grew by 93.1% over the past year

Risk Analysis

No risks detected for AFX from our risk checks.

Carl Zeiss Meditec Competitors

Johnson & Johnson

NYSE:JNJ

US$434.0b

Novartis

SWX:NOVN

CHF178.7b

General Electric

NYSE:GE

US$105.7b

HOYA

TSE:7741

JP¥5.6t

Price History & Performance

Summary of all time highs, changes and price drops for Carl Zeiss Meditec
Historical stock prices
Current Share Price€142.05
52 Week High€202.00
52 Week Low€119.50
Beta0.36
1 Month Change-22.38%
3 Month Change-16.61%
1 Year Change8.35%
3 Year Change80.84%
5 Year Change302.47%
Change since IPO305.86%

Recent News & Updates

Dec 12
Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

Here's Why We Think Carl Zeiss Meditec (ETR:AFX) Is Well Worth Watching

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Nov 06
Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

Carl Zeiss Meditec (ETR:AFX) Has Some Way To Go To Become A Multi-Bagger

There are a few key trends to look for if we want to identify the next multi-bagger. Amongst other things, we'll want...

Sep 06
If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

If You Like EPS Growth Then Check Out Carl Zeiss Meditec (ETR:AFX) Before It's Too Late

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Shareholder Returns

AFXDE Medical EquipmentDE Market
7D-3.6%0.9%-2.0%
1Y8.4%24.4%8.1%

Return vs Industry: AFX underperformed the German Medical Equipment industry which returned 27.6% over the past year.

Return vs Market: AFX underperformed the German Market which returned 10% over the past year.

Price Volatility

Is AFX's price volatile compared to industry and market?
AFX volatility
AFX Average Weekly Movement5.9%
Medical Equipment Industry Average Movement5.4%
Market Average Movement5.0%
10% most volatile stocks in DE Market9.7%
10% least volatile stocks in DE Market2.7%

Stable Share Price: AFX is not significantly more volatile than the rest of German stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: AFX's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18463,531n/ahttps://www.zeiss.de/meditec-ag/home.html

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.

Carl Zeiss Meditec Fundamentals Summary

How do Carl Zeiss Meditec's earnings and revenue compare to its market cap?
AFX fundamental statistics
Market Cap€12.71b
Earnings (TTM)€236.28m
Revenue (TTM)€1.65b

53.8x

P/E Ratio

7.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AFX income statement (TTM)
Revenue€1.65b
Cost of Revenue€679.57m
Gross Profit€967.21m
Expenses€730.94m
Earnings€236.28m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 11, 2022

Earnings per share (EPS)2.64
Gross Margin58.73%
Net Profit Margin14.35%
Debt/Equity Ratio0%

How did AFX perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

34%

Payout Ratio

Does AFX pay a reliable dividends?

See AFX dividend history and benchmarks
When do you need to buy AFX by to receive an upcoming dividend?
Carl Zeiss Meditec dividend dates
Ex Dividend DateMar 31 2022
Dividend Pay DateApr 04 2022
Days until Ex dividend67 days
Days until Dividend pay date71 days

Does AFX pay a reliable dividends?

See AFX dividend history and benchmarks

Valuation

Is Carl Zeiss Meditec undervalued compared to its fair value and its price relative to the market?

53.77x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: AFX (€142.05) is trading above our estimate of fair value (€114.6)

Significantly Below Fair Value: AFX is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AFX is poor value based on its PE Ratio (53.8x) compared to the German Medical Equipment industry average (26.8x).

PE vs Market: AFX is poor value based on its PE Ratio (53.8x) compared to the German market (20.7x).


Price to Earnings Growth Ratio

PEG Ratio: AFX is poor value based on its PEG Ratio (5.7x)


Price to Book Ratio

PB vs Industry: AFX is overvalued based on its PB Ratio (7.7x) compared to the DE Medical Equipment industry average (4.3x).


Future Growth

How is Carl Zeiss Meditec forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

9.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AFX's forecast earnings growth (9.5% per year) is above the savings rate (-0.01%).

Earnings vs Market: AFX's earnings (9.5% per year) are forecast to grow slower than the German market (10.7% per year).

High Growth Earnings: AFX's earnings are forecast to grow, but not significantly.

Revenue vs Market: AFX's revenue (8% per year) is forecast to grow faster than the German market (5.7% per year).

High Growth Revenue: AFX's revenue (8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AFX's Return on Equity is forecast to be low in 3 years time (14.7%).


Past Performance

How has Carl Zeiss Meditec performed over the past 5 years?

11.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AFX has high quality earnings.

Growing Profit Margin: AFX's current net profit margins (14.3%) are higher than last year (9.2%).


Past Earnings Growth Analysis

Earnings Trend: AFX's earnings have grown by 11.5% per year over the past 5 years.

Accelerating Growth: AFX's earnings growth over the past year (93.1%) exceeds its 5-year average (11.5% per year).

Earnings vs Industry: AFX earnings growth over the past year (93.1%) exceeded the Medical Equipment industry 76.9%.


Return on Equity

High ROE: AFX's Return on Equity (14.2%) is considered low.


Financial Health

How is Carl Zeiss Meditec's financial position?


Financial Position Analysis

Short Term Liabilities: AFX's short term assets (€1.6B) exceed its short term liabilities (€448.1M).

Long Term Liabilities: AFX's short term assets (€1.6B) exceed its long term liabilities (€270.5M).


Debt to Equity History and Analysis

Debt Level: AFX is debt free.

Reducing Debt: AFX had no debt 5 years ago.

Debt Coverage: AFX has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: AFX has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Carl Zeiss Meditec current dividend yield, its reliability and sustainability?

0.63%

Current Dividend Yield


Upcoming Dividend Payment

TodayJan 22 2022Ex Dividend DateMar 31 2022Dividend Pay DateApr 04 20224 days from Ex DividendBuy in the next 67 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: AFX's dividend (0.63%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1%).

High Dividend: AFX's dividend (0.63%) is low compared to the top 25% of dividend payers in the German market (3.33%).


Stability and Growth of Payments

Stable Dividend: AFX's dividends per share have been stable in the past 10 years.

Growing Dividend: AFX's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (34.1%), AFX's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: AFX's dividends in 3 years are forecast to be well covered by earnings (36.4% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average management tenure


CEO

Carl Zeiss Meditec has no CEO, or we have no data on them.


Leadership Team

Experienced Management: AFX's management team is considered experienced (3.3 years average tenure).


Board Members

Experienced Board: AFX's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Carl Zeiss Meditec AG's employee growth, exchange listings and data sources


Key Information

  • Name: Carl Zeiss Meditec AG
  • Ticker: AFX
  • Exchange: XTRA
  • Founded: 1846
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: €12.705b
  • Shares outstanding: 89.44m
  • Website: https://www.zeiss.de/meditec-ag/home.html

Number of Employees


Location

  • Carl Zeiss Meditec AG
  • Goschwitzer Strasse 51-52
  • Jena
  • Thuringia
  • 7745
  • Germany

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/21 21:19
End of Day Share Price2022/01/21 00:00
Earnings2021/09/30
Annual Earnings2021/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.